QI GRIJALVA: Open Payments
NPI 1952043671 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 9 payments from 7 companies in 2025. Trend: 2023 $387 · 2024 $517 · 2025 $842
Food & beverage: $491Travel & lodging: $351
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 3 | $493 |
| Abbott Laboratories | 1 | $165 |
| ABIOMED | 1 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| SCPHARMACEUTICALS INC. | 1 | $17 |
| Stryker Corporation | 1 | $14 |
Products named: Barostim Neo System, ENSITE, JARDIANCE, FARXIGA, FUROSCIX, FLOWTRIEVER.
Industry payments across TX — which companies pay providers there.
